Daily massage may ease swelling in preterm infants, small trial hopes
NCT ID NCT07418814
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily 15-minute massage for 14 days can reduce swelling (lymphedema) and improve comfort in 40 premature babies in the NICU. Half the infants will receive standard care, and the other half will also get gentle massage on their arms and legs. Researchers will measure changes in limb size and use a comfort scale to see if the massage helps.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
infant massage therapy
What this could lead to
If it works, this could offer a safe, non-drug way to reduce swelling and distress in premature babies in the NICU.
What could go wrong
This is a very small early trial (40 infants) with no blinding, so results may not be reliable or generalizable. The massage may not reduce swelling more than standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••